Published in Biochem Biophys Res Commun on April 02, 2011
Variation in dietary salt intake induces coordinated dynamics of monocyte subsets and monocyte-platelet aggregates in humans: implications in end organ inflammation. PLoS One (2013) 1.00
Epithelial-mesenchymal transition and fibrosis are mutually exclusive reponses in shear-activated proximal tubular epithelial cells. FASEB J (2012) 0.88
On-chip evaluation of shear stress effect on cytotoxicity of mesoporous silica nanoparticles. Anal Chem (2011) 0.84
Soluble thrombomodulin reduces inflammation and prevents microalbuminuria induced by chronic endothelial activation in transgenic mice. Am J Physiol Renal Physiol (2011) 0.77
Shear Stress-Induced Alteration of Epithelial Organization in Human Renal Tubular Cells. PLoS One (2015) 0.75
Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Circ Res (2008) 2.12
Urine in clinical proteomics. Mol Cell Proteomics (2008) 2.05
Obstructive nephropathy: insights from genetically engineered animals. Kidney Int (2005) 1.97
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
Partial inhibition of adipose tissue lipolysis improves glucose metabolism and insulin sensitivity without alteration of fat mass. PLoS Biol (2013) 1.87
Critical role of tissue kallikrein in vessel formation and maturation: implications for therapeutic revascularization. Arterioscler Thromb Vasc Biol (2009) 1.67
Recommendations for biomarker identification and qualification in clinical proteomics. Sci Transl Med (2010) 1.59
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics. Proteomics Clin Appl (2008) 1.57
Anomalies of the TCF2 gene are the main cause of fetal bilateral hyperechogenic kidneys. J Am Soc Nephrol (2007) 1.56
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis. Nat Med (2006) 1.52
Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res (2007) 1.52
LPA1 receptor activation promotes renal interstitial fibrosis. J Am Soc Nephrol (2007) 1.51
Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol (2010) 1.48
Proteome-based systems biology analysis of the diabetic mouse aorta reveals major changes in fatty acid biosynthesis as potential hallmark in diabetes mellitus-associated vascular disease. Circ Cardiovasc Genet (2014) 1.44
Capillary electrophoresis-mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments. Mass Spectrom Rev (2009) 1.19
Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics (2010) 1.16
Developing a kidney and urinary pathway knowledge base. J Biomed Semantics (2011) 1.13
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl (2010) 1.12
The human urinary proteome reveals high similarity between kidney aging and chronic kidney disease. Proteomics (2009) 1.11
Populous: a tool for building OWL ontologies from templates. BMC Bioinformatics (2012) 1.10
Lysophosphatidic acid and renal fibrosis. Biochim Biophys Acta (2008) 1.04
CE-MS in biomarker discovery, validation, and clinical application. Proteomics Clin Appl (2010) 1.02
In vivo bradykinin B2 receptor activation reduces renal fibrosis. J Clin Invest (2002) 1.01
The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy. Proteomics Clin Appl (2008) 1.01
Implementation of proteomic biomarkers: making it work. Eur J Clin Invest (2012) 1.00
Congenital ureteropelvic junction obstruction: human disease and animal models. Int J Exp Pathol (2010) 0.99
Kinin B1 receptor deficiency leads to leptin hypersensitivity and resistance to obesity. Diabetes (2008) 0.96
ACE inhibitor reduces growth factor receptor expression and signaling but also albuminuria through B2-kinin glomerular receptor activation in diabetic rats. Am J Physiol Renal Physiol (2007) 0.94
Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opin Investig Drugs (2011) 0.94
Shear-flow induced detachment of Saccharomyces cerevisiae from stainless steel: influence of yeast and solid surface properties. Colloids Surf B Biointerfaces (2006) 0.92
The bradykinin B1 receptor contributes to the cardioprotective effects of AT1 blockade after experimental myocardial infarction. Cardiovasc Res (2004) 0.92
Blockade of the kinin B1 receptor ameloriates glomerulonephritis. J Am Soc Nephrol (2010) 0.91
Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment. Circulation (2002) 0.90
Expression of NOS1 and soluble guanylyl cyclase by human kidney epithelial cells: morphological evidence for an autocrine/paracrine action of nitric oxide. Kidney Int (2003) 0.90
Long term metabolic syndrome induced by a high fat high fructose diet leads to minimal renal injury in C57BL/6 mice. PLoS One (2013) 0.90
Measuring kinetic dissociation/association constants between Lactococcus lactis bacteria and mucins using living cell probes. Biophys J (2011) 0.90
Identification of urinary biomarkers by proteomics in newborns: use in obstructive nephropathy. Contrib Nephrol (2008) 0.90
A novel protein-protein interaction between a G protein-coupled receptor and the phosphatase SHP-2 is involved in bradykinin-induced inhibition of cell proliferation. J Biol Chem (2002) 0.90
Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model. Am J Physiol Renal Physiol (2008) 0.90
Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation. Can J Physiol Pharmacol (2002) 0.89
Clinical proteomics in obstetrics and neonatology. Expert Rev Proteomics (2014) 0.88
Probing in vitro interactions between Lactococcus lactis and mucins using AFM. Langmuir (2010) 0.88
Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application. Adv Chronic Kidney Dis (2010) 0.88
Decreased renal NO excretion and reduced glomerular tuft area in mice lacking the bradykinin B2 receptor. Am J Physiol Heart Circ Physiol (2003) 0.88
Non-invasive markers of ureteropelvic junction obstruction. World J Urol (2007) 0.88
Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci Transl Med (2013) 0.87
Capillary electrophoresis-mass spectrometry in urinary proteome analysis: current applications and future developments. Anal Bioanal Chem (2008) 0.87
The KUPKB: a novel Web application to access multiomics data on kidney disease. FASEB J (2012) 0.87
Loss of Pgc-1α expression in aging mouse muscle potentiates glucose intolerance and systemic inflammation. Am J Physiol Endocrinol Metab (2013) 0.87
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol (2009) 0.87
Role of the kinin B1 receptor in insulin homeostasis and pancreatic islet function. Biol Chem (2006) 0.86
Urinary proteomics and molecular determinants of chronic kidney disease: possible link to proteases. Expert Rev Proteomics (2014) 0.85
Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor. Biochem Biophys Res Commun (2009) 0.85
Evaluation of the Zucker diabetic fatty (ZDF) rat as a model for human disease based on urinary peptidomic profiles. PLoS One (2012) 0.85
Chronic kidney disease in children: the National Paediatric Hospital experience in Hanoi, Vietnam. Nephrology (Carlton) (2009) 0.85
Systems biology: opening new avenues in clinical research. Nephrol Dial Transplant (2010) 0.84
Renal fibrosis: insight from proteomics in animal models and human disease. Proteomics (2011) 0.84
Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis. Exp Biol Med (Maywood) (2009) 0.84
Renal tubular fluid shear stress facilitates monocyte activation toward inflammatory macrophages. Am J Physiol Renal Physiol (2012) 0.84